Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.47 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5653478 | 0.86 | KEAP1 (0.41) | KEAP1NAPRTKDM4EMAPTGAA | |
| SCHEMBL311990 | 0.84 | KEAP1 (0.40) | KEAP1NAPRTKDM4EMAPTGAA | |
| SCHEMBL29042806 | 0.81 | RAB9A (0.41) | KEAP1NAPRTKDM4EMAPTGAA | |
| SCHEMBL27820698 | 0.81 | CNR2 (0.42) | KEAP1NAPRTKDM4EMAPTGAA | |
| SCHEMBL10943013 | 0.78 | AKR1C3 (0.55) | KEAP1NAPRTKDM4EMAPTGAA | |
| SCHEMBL27820699 | 0.78 | NR4A2 (0.43) | KDM4EMAPTGAAALDH1A1ALOX15 | |
| SCHEMBL5173312 | 0.77 | — | — | |
| SCHEMBL161489 | 0.77 | — | — | |
| SCHEMBL5174393 | 0.77 | — | — | |
| SCHEMBL5173735 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1282 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122089256-A | Assembled hydraulic loop geological information system architecture | — | 2026-05-26 | — | — | CN | claimed |
| CN-122048180-A | Self-optimizing method and system for quality system based on PDCA (digital versatile framework) cycle | 四川航泰航空装备有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122022509-A | Power industry management innovation system based on QC activity group | 国网河南省电力公司襄城县供电公司 | 2026-05-12 | — | — | CN | claimed |
| US-12611384-B2 | Antimicrobial nanoworms | THE BOEING COMPANY (US) | 2026-04-28 | — | — | US | claimed |
| CN-120059154-A | In C4Method for producing polybutylene succinate polyester by taking unsaturated binary oxygen-containing compound as raw material | 上海师范大学 | 2025-05-30 | — | — | CN | claimed |
| CN-119996281-A | Industry digital router integrating AI digital ecology | 上海司百袖信息技术有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119894504-A | Inhalable formulation for treating bacterial infections in the lungs | 索米克生物技术有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119863117-A | Operation high risk identification and early warning method based on artificial intelligence technology | 北京国网信通埃森哲信息技术有限公司 | 2025-04-22 | — | — | CN | claimed |
| CN-119809317-A | Multidimensional risk factor index identification method based on artificial intelligence technology | 北京国网信通埃森哲信息技术有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119784122-A | Sealing operation flow arrangement optimization method | 辽宁理工职业大学 | 2025-04-08 | — | — | CN | claimed |
| CN-114077938-A | Method and system for managing PDCA project | 华晨宝马汽车有限公司 | 2022-02-22 | — | — | CN | claimed |
| WO-2022034357-A1 | PROCESS FOR PREPARING SPHERICAL POLYMERIC PARTICLES FOR COSMETIC APPLICATION | RHODIA BRASIL S.A. (BR) | 2022-02-17 | — | — | WO | claimed |
| US-20200215208-A1 | COMPOSITIONS COMPRISING MELANIN, AND METHODS OF PREPARING AND USES THEREOF | RESEARCH & BUSINESS FOUNDATION, SUNGKYUNKWAN UNIVERSITY (KR) | 2020-07-09 | — | — | US | claimed |
| US-20200181782-A1 | ELECTROCHEMICAL REDUCTIVE CARBOXYLATION OF UNSATURATED ORGANIC SUBSTRATES IN IONICALLY CONDUCTIVE MEDIUMS | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2020-06-11 | — | — | US | claimed |
| WO-2019021035-A1 | COMPOSITIONS COMPRISING MELANIN, AND METHODS OF PREPARING AND USES THEREOF | MELANIS CO., LTD. (KR) | 2019-01-31 | — | — | WO | claimed |
| WO-2019023532-A1 | ELECTROCHEMICAL REDUCTIVE CARBOXYLATION OF UNSATURATED ORGANIC SUBSTRATES IN IONICALLY CONDUCTIVE MEDIUMS | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2019-01-31 | — | — | WO | claimed |
| US-8653048-B2 | Prodrugs based on gemcitabine structure and synthetic methods and applications thereof | SANLUGEN PHARMATECH LTD. (CN) | 2014-02-18 | — | — | US | claimed |
| CN-102428093-A | Prodrugs based on gemcitabine structure as well as synthetic method and application thereof | SANLUGEN PHARMATECH LTD | 2012-04-25 | — | — | CN | claimed |
| US-20120088908-A1 | Prodrugs Based on Gemcitabine Structure and Synthetic Methods and Applications Thereof | SANLUGEN PHARMATECH LTD. (CN) | 2012-04-12 | — | — | US | claimed |
| EP-2423215-A1 | PRODRUGS BASED ON GEMCITABINE STRUCTURE AS WELL AS SYNTHETIC METHOD AND APPLICATION THEREOF | Sanlugen Pharmatech Ltd. (CN) | 2012-02-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200215208-A1 | COMPOSITIONS COMPRISING MELANIN, AND METHODS OF PREPARING AND USES THEREOF | TYR, MCHR1, MCHR2 | KEAP1 471/4885NAPRT 2833/4885KDM4E 3704/4885 |
| US-20120088908-A1 | Prodrugs Based on Gemcitabine Structure and Synthetic Methods and Applications Thereof | TYMP, DCTD, GLS2 | KEAP1 4836/4885NAPRT 671/4885KDM4E 2472/4885 |
| US-12611384-B2 | Antimicrobial nanoworms | LCT, DNPEP, CLTA | KEAP1 2017/4885NAPRT 1166/4885KDM4E 3213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.